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Introduction / objectives
Clostridium difficile reporting is mandatory in England,
numbers have increased since the mid-1990s with over
25 000 reported per year. At Imperial College Healthcare it
was observed that isolation of C. difficile from stool did not
always reflect clinical disease; particularly when testing was
changedto detection of glutamate dehydrogenase (GDH)
and the tcdB gene by PCR. Testing for C. difficile in liquid
stools was not restricted. All positive patients were there-
fore reviewed to determine if they had C. difficile associated
disease (CDAD).
Methods
A patient was considered to have CDAD if they had at
least 3 episodes of diarrhoea in 24 hours, the stool was
positive for C. difficile by PCR, diarrhoea was not attribu-
table to another cause and symptoms consistent with
pseudomembranous colitis. A standardised clinical review
was undertaken to determine if new cases of C. difficile
met the case definition. Data were captured prospectively
on an electronic surveillance system (ICNet).
Results
250 patients admitted between June 2010 and January 2011
were test positive; of these, 166 (66%) were classified as hos-
pital-acquired. Clinical review found 67 (40%) did not have
CDAD: 29 (27%) did not have diarrhoea; in 80 (73%), diar-
rhoea was attributable to another cause, most commonly
underlying bowel disease (38 cases). Severe disease
occurred in 16%; there were 7 deaths associated with
CDAD.
Conclusion
This analysis indicates that improved laboratory tests for
toxin-producing C. difficile do not correlate well with
CDAD. Whilst this may be an advantage in terms of
prompt initiation of infection control measures, reporting
based on positive tests does not represent the true burden
of disease and the laboratory method used diagnosis may
have a significant impact on rates.
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